Standard Ebit from 2010 to 2026
| LAB Stock | USD 1.36 0.05 3.55% |
EBIT | First Reported 2009-12-31 | Previous Quarter -18.3 M | Current Value -32.9 M | Quarterly Volatility 12.6 M |
Check Standard Biotools financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Standard Biotools' main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.9 M, Interest Expense of 4.4 M or Total Revenue of 210.6 M, as well as many indicators such as Price To Sales Ratio of 4.32, Dividend Yield of 0.0 or PTB Ratio of 1.93. Standard financial statements analysis is a perfect complement when working with Standard Biotools Valuation or Volatility modules.
Standard | Ebit | Build AI portfolio with Standard Stock |
Analyzing Standard Biotools's Ebit over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Ebit has evolved provides context for assessing Standard Biotools's current valuation and future prospects.
Latest Standard Biotools' Ebit Growth Pattern
Below is the plot of the Ebit of Standard Biotools over the last few years. It is Standard Biotools' EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Standard Biotools' overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
Standard Ebit Regression Statistics
| Arithmetic Mean | (68,064,352) | |
| Coefficient Of Variation | (69.45) | |
| Mean Deviation | 34,837,514 | |
| Median | (57,975,000) | |
| Standard Deviation | 47,271,063 | |
| Sample Variance | 2234.6T | |
| Range | 172.2M | |
| R-Value | (0.79) | |
| Mean Square Error | 881.2T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | (7,431,830) | |
| Total Sum of Squares | 35752.9T |
Standard Ebit History
Other Fundumenentals of Standard Biotools
About Standard Biotools Financial Statements
Standard Biotools stakeholders use historical fundamental indicators, such as Standard Biotools' Ebit, to determine how well the company is positioned to perform in the future. Although Standard Biotools investors may analyze each financial statement separately, they are all interrelated. For example, changes in Standard Biotools' assets and liabilities are reflected in the revenues and expenses on Standard Biotools' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Standard Biotools. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBIT | -121.5 M | -115.4 M | |
| EBITDA | -106.3 M | -101 M | |
| Ebt Per Ebit | 0.71 | 0.88 | |
| Ebit Per Revenue | (0.90) | (0.95) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:Check out the analysis of Standard Biotools Correlation against competitors. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. Expected growth trajectory for Standard significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Standard Biotools assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.39) | Revenue Per Share | Quarterly Revenue Growth (0.14) | Return On Assets | Return On Equity |
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Standard Biotools' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Standard Biotools represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Standard Biotools' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.